Related Articles
Lenvatinib‑based treatment regimens in conversion therapy of unresectable hepatocellular carcinoma: A systematic review and meta‑analysis
A retrospective study of transarterial chemoembolization (TACE) combined with lenvatinib compared with TACE monotherapy for BCLC B2 stage hepatocellular carcinoma
Effect of the timing of discontinuation of last‑line chemotherapy on patient prognosis in advanced and recurrent gastric cancer
Primary ovarian insufficiency associated with lenvatinib therapy in a patient with hepatocellular carcinoma: A case report
Relationship between adverse events associated with lenvatinib treatment for thyroid cancer and patient prognosis